CYP2E1 in 1,4-dioxane metabolism and liver toxicity: insights from CYP2E1 knockout mice study

Yewei Wang1,2, Georgia Charkoftaki1, David J Orlicky3

  • 1Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.

Archives of Toxicology
|August 27, 2024
PubMed

Insights

1,4-Dioxane (DX) liver carcinogenicity is linked to CYP2E1 enzyme activity. Studies show CYP2E1 deficiency protects against DX-induced liver damage and oxidative stress, suggesting it

Area of Science:

  • Environmental Health
  • Toxicology
  • Biochemistry

Background:

  • 1,4-Dioxane (DX) is an emerging water contaminant and a potential liver carcinogen.
  • Previous research links high-dose DX exposure to liver cytotoxicity, oxidative DNA damage, CYP2E1 induction, and oxidative stress in mice.
  • Understanding the role of Cytochrome P450 2E1 (CYP2E1) in DX metabolism and toxicity is crucial for risk assessment.

Purpose of the Study:

  • To investigate the role of CYP2E1 in 1,4-Dioxane metabolism and its contribution to DX-induced liver toxicity and carcinogenicity.
  • To compare DX effects in CYP2E1-deficient mice with wildtype and glutathione-deficient mice.

Main Methods:

  • Exposure of male and female Cyp2e1-null mice to 1,4-Dioxane (5000 ppm) in drinking water for 1 week or 3 months.
  • Analysis of DX metabolism, hepatic redox status (lipid peroxidation, glutathione oxidation, NRF2 activation), oxidative DNA damage, and DNA repair responses.
  • Cross-study comparisons with similarly treated male wildtype (WT) and Gclm-null mice.

Main Results:

  • Cyp2e1-null mice exhibited resistance to DX-induced hepatocellular cytotoxicity.
  • In male Cyp2e1-null mice, DX metabolism was reduced, hepatic redox dysregulation was attenuated, and oxidative DNA damage was comparable to WT mice, with suppressed DNA repair.
  • No preneoplastic lesions were observed in DX-exposed Cyp2e1-null mouse livers.

Conclusions:

  • CYP2E1 is the primary enzyme responsible for high-dose 1,4-Dioxane metabolism and a key contributor to DX-induced liver oxidative stress and cytotoxicity.
  • High-dose DX-induced genotoxicity may involve CYP2E1-independent pathways, potentially related to impaired DNA damage repair.
  • These findings are critical for understanding DX liver carcinogenicity mechanisms and informing risk assessment strategies.

Related Concept Videos

Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...